Towards Healthcare
Parkinson's Disease Diagnosis and Treatment Market Growth | Trends

Parkinson's Disease Diagnosis and Treatment Market Size Envisioned at USD 14.36 Billion by 2032

The report covers Parkinson's Disease Diagnosis and Treatment Market Companies and Segments involves employing imaging tests, blood tests, and other diagnostic procedures. Treatment options include medications such as Carbidopa-levodopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics and other emerging therapies. Additionally, Deep Brain Stimulation and other treatment modalities offer alternatives for managing symptoms. Geographically, the market spans North America, Europe, Asia Pacific, Middle East and Africa, and South America. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value chain analysis
    • Raw material sourcing
    • Manufacturing process
    • Logistics & transportation
    • Buyer preferences
  • Trends
    • Market trends
    • Technological trends
  • Porter’s Five Forces Analysis
    • Bargaining power of suppliers
    • Bargaining power of buyers
    • Threat of substitute
    • Threat of new entrants
    • Degree of competition
  • PESTLE Analysis for 5 leading countries
    • Regulatory framework for leading countries/regions
    • Supply demand analysis
    • Production & consumption statistics
    • Export Import statistics
    • Price trend analysis

Global Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments
  • Global Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • North America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Europe Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Europe Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Asia Pacific Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • Middle East and Africa Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

South America Parkinson's Disease Diagnosis and Treatment Market Assessment

  • Overview
  • South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Diagnosis (2021 – 2033)
    • Imaging Tests
    • Blood Tests
    • Other Tests
  • South America Parkinson's Disease Diagnosis and Treatment Market Size Value (US$) and Volume (Billion Tons), by Treatment (2021 – 2033)
    • Medications 
      • Carbidopa-levodopa
      • Dopamine Agonists
      • MAO-B Inhibitors
      • COMT Inhibitors
      • Anticholinergics
      • Others
    • Deep Brain Stimulation
    • Other Treatments

Company Profiles

  • Siemens Healthineers AG
    • Company overview
    • Geographic footprints
    • Financial performance
    • Product portfolio
    • SWOT analysis
    • R&D efforts
    • Recent developments & strategic collaborations
      • Product launch/M&A/Technical collaboration
  • Abbott Laboratories
  • General Electric Company
  • AbbVie
  • Merck & Co.
  • Pfizer
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharma
  • Novartis AG
  • Cerevel Therapeutics

Conclusion & Recommendations

  • Insight Code: 5142
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Symptoms of Parkinsons disease include tremors, stiffness, slow movement, and problems with balance and coordination.

North America leads the market for Parkinsons disease diagnosis and treatment.

Deep Brain Stimulation (DBS) is a surgical procedure where electrodes are implanted into specific areas of the brain. These electrodes deliver electrical impulses to regulate abnormal brain activity, helping to alleviate symptoms of movement disorders like Parkinsons disease.

Department of Health, State Government of Victoria, Australia, U.S. Department of Veterans Affairs, National Institute of Health, WHO

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515